logo
  

Pacific Biosciences of California, Inc. Q2 Loss Increases, misses estimates

Pacific Biosciences of California, Inc. (PACB) revealed Loss for its second quarter that increased from the same period last year in line with the Street estimates.

The company's earnings totaled -$71.39 million, or -$0.32 per share. This compares with -$41.00 million, or -$0.21 per share, in last year's second quarter.

Excluding items, Pacific Biosciences of California, Inc. reported adjusted earnings of -$76.60 million or -$0.34 per share for the period.

Analysts on average had expected the company to earn -$0.32 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 15.9% to $35.47 million from $30.61 million last year.

Pacific Biosciences of California, Inc. earnings at a glance (GAAP) :

-Earnings (Q2): -$71.39 Mln. vs. -$41.00 Mln. last year.
-EPS (Q2): -$0.32 vs. -$0.21 last year.
-Analyst Estimate: -$0.32
-Revenue (Q2): $35.47 Mln vs. $30.61 Mln last year.

-Guidance:
Full year revenue guidance: $138 - $145 Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT